Trial · NCT07900217
A Clinical Study to Assess the Effects of a Dark Spot Corrector on Dark Spots and Overall Complexion
NCT07900217, Not applicable, Completed, Dime Beauty Co.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Clinical Study to Assess the Effects of a Dark Spot Corrector on Dark Spots and Overall Complexion. Trials, record NCT07900217. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07900217
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Clinical Study to Assess the Effects of a Dark Spot Corrector on Dark Spots and Overall Complexion
- NCT number
- NCT07900217
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 35 participants, actual
- Lead sponsor
- Dime Beauty Co.
- Conditions
- Hyperpigmentation, Dark Spots, Skin Complexion
- Interventions
- Dark Spot Corrector Group
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in dark spot visibility as assessed by self-reported questionnaire | Baseline, Day 14, Day 30, Day 60, and Day 90 | Participant-reported reduction in the visibility of dark spots on the face, measured via subject-specific self-reported questionnaires |
| Primary | Change in dark spot visibility as assessed by expert skin grading of photographs | Baseline, Day 30, Day 60, and Day 90 | Expert-graded evaluation of dark spot visibility using standardized facial photographs (front, left, and right sides) |
| Secondary | Change in skin brightness | Baseline, Day 14, Day 30, Day 60, and Day 90 | Participant-reported improvement in skin brightness assessed via subject-specific self-reported questionnaires |
| Secondary | Change in skin smoothness | Baseline, Day 14, Day 30, Day 60, and Day 90 | Participant-reported improvement in skin smoothness assessed via subject-specific self-reported questionnaires |
| Secondary | Change in skin radiance | Baseline, Day 14, Day 30, Day 60, and Day 90 | Participant-reported improvement in skin radiance assessed via subject-specific self-reported questionnaires |
| Secondary | Change in evenness of complexion | Baseline, Day 14, Day 30, Day 60, and Day 90 | Participant-reported improvement in evenness of complexion assessed via subject-specific self-reported questionnaires |
| Secondary | Change in skin appearance as assessed by expert skin grading of photographs | Baseline, Day 30, Day 60, and Day 90 | Expert-graded evaluation of skin brightness, smoothness, radiance, and complexion evenness using standardized facial photographs |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07900217
GET https://conductscience.org/api/trials/v1/NCT07900217/registered